Information:
Fel:
ID
34275
Beskrivning
Proof of Confidence Study of CCR2 Antagonist (BMS-741672) in Insulin Resistance; ODM derived from: https://clinicaltrials.gov/show/NCT00699790
Länk
https://clinicaltrials.gov/show/NCT00699790
Nyckelord
Versioner (1)
- 2019-01-16 2019-01-16 -
Rättsinnehavare
see on clinicaltrials.gov
Uppladdad den
16 januari 2019
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Diabetes Mellitus, Non-Insulin-Dependent NCT00699790
Eligibility Diabetes Mellitus, Non-Insulin-Dependent NCT00699790
- StudyEvent: Eligibility
Similar models
Eligibility Diabetes Mellitus, Non-Insulin-Dependent NCT00699790
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
ID.1
Item
drug-naive type 2 diabetics with a screening hba1c of ≥ 7.5% and ≤ 10%
boolean
ID.2
Item
screening fpg ≥ 140 mg/dl and ≤ 220 mg/dl
boolean
ID.3
Item
bmi ≤ 40 kg/m2
boolean
ID.4
Item
active tuberculosis
boolean
ID.5
Item
symptoms of poorly controlled diabetes
boolean
ID.6
Item
history of diabetic ketoacidosis
boolean
ID.7
Item
significant cardiovascular history or gastrointestinal disorders
boolean
ID.8
Item
history of unstable or rapidly progressing renal disease
boolean
ID.9
Item
active liver disease and/or significant abnormal liver function
boolean
ID.10
Item
abnormal chest x-ray at screening indicative of tuberculosis or other infection
boolean